Botulinum Toxin-Associated Prolonged Remission of Idiopathic Cervical Dystonia

Can J Neurol Sci. 2021 Nov;48(6):864-868. doi: 10.1017/cjn.2020.280. Epub 2021 Jan 5.

Abstract

Prolonged remission of dystonia occurs rarely; however, well-documented cases are lacking. We report the clinical characteristics and course of four patients with botulinum toxin (BoNT)-associated prolonged remission of idiopathic cervical dystonia. Mean age at onset was 40 years. All had a relatively short duration of symptoms (mean 10.3 months), and with remission occurring after ≤ 3 treatments with BoNT. At last examination, the remission duration was 2-5 years. In the two cases that subsequently relapsed after 4-5 years, there was an altered phenomenology and worsened severity than at the onset. Recognizing this rare phenomenon has valuable clinical implications.

Keywords: Botulinum toxin; Cervical dystonia; Dystonia; Relapse; Remission.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Botulinum Toxins* / therapeutic use
  • Humans
  • Neuromuscular Agents* / therapeutic use
  • Time Factors
  • Torticollis* / drug therapy

Substances

  • Neuromuscular Agents
  • Botulinum Toxins